Alnylam Keeps Making New Strides In RNAi Research By: TalkMarkets October 14, 2014 at 16:46 PM EDT Alnylam posts positive phase 2 results in open-label study. Read More >> Related Stocks: Alnylam Pharmaceuticals Sanofi-Aventis S.A. ADR